EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Prevalence of glucose-6-phosphate dehydrogenase (G6PD) deficiency in a malaria endemic region of Colombia: Implications for radical cure of Plasmodium vivax

Lina Zuluaga-Idárraga iD, Alexandra Rios-Orrego iD, Juan Esteban Martinez-López iD, Daniel Camilo Aguirre-Acevedo iD, Alberto Tobón-Castaño iD, Tatiana Lopera-Mesa iD, Iván Cardenas iD, Mario J Olivera iD, Milton Cardozo-Cruz iD, Guillermo Gonzalvez iD, María Paz Ade, Roberto Montoya und 8 weitere

PLOS Global Public Health · 11.11.2026 · 6 (11) · e0007460

DOI: 10.1371/journal.pgph.0007460 ↗

Kurz gefasst

Fachartikel in der Zeitschrift PLOS Global Public Health, online erschienen am 11.11.2026. Verfasst von Lina Zuluaga-Idárraga und 19 weiteren Autor:innen. Beteiligte Einrichtung: Grupo Malaria, Facultad de Medicina, Universidad de Antioquia, Medellín, Antioquia, Colombia. Die Arbeit nennt 48 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: U.S. Department of State.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Glucose-6-phosphate dehydrogenase deficiency (G6PDd) has important implications for the treatment of Plasmodium vivax , the predominant malaria species in Latin America. The only drug class available for P. vivax radical cure, the 8-aminoquinolines, can induce hemolysis in individuals with G6PDd. However, G6PDd prevalence among subpopulations and its relationship with Plasmodium infection remain poorly characterized. In Quibdó, Colombia, an area co-endemic for P. vivax and Plasmodium falciparum , cross-sectional surveys were conducted in three groups: 1) the general population, 2) Emberá dobida indigenous communities, and 3) febrile outpatients. G6PD status was determined using a quantitative test (STANDARD™ G6PD Test, SD BIOSENSOR, South Korea), and Plasmodium infection was assessed by polymerase chain reaction. G6PD activity was classified as deficient (≤4.0 IU/g hemoglobin), intermediate (4.1–6.0 in females), or normal (≥6.1 in females, ≥ 4.1 in males). Among 1,267, 194, and 542 participants in groups 1, 2, and 3, respectively, G6PDd prevalence was 10.4% overall and 13.7% among males in the predominantly Afro-Colombian general population, with no cases among indigenous participants. Among febrile outpatients, G6PDd prevalence was 6.9% overall and 8.2% among males, with a comparable but slightly lower prevalence among those with confirmed malaria. Plasmodium infection prevalence was 17.8%, 40.7%, and 47.8%, respectively. P. vivax mono-infection predominated in community surveys (59.1% and 60.8%), whereas P. falciparum predominated among febrile outpatients (55.6%). After adjustment for sex, Afro-Colombian ethnicity, and prior malaria, G6PD-deficient individuals in the asymptomatic general population had a lower risk of Plasmodium infection, primarily P. vivax (aPR, 0.05; 95% CI, 0.01–0.18), and none had P. vivax infection. These findings highlight high G6PDd prevalence among Afro-Colombians and its absence among an indigenous population with the highest P. vivax burden, suggesting that G6PDd may confer partial protection against P. vivax . This information can inform prioritization of more effective radical cure for at-risk subpopulations.

Autor:innen und Institutionen

  • Grupo Malaria, Facultad de Medicina, Universidad de Antioquia, Medellín, Antioquia, Colombia.
  • Grupo Epidemiología, Facultad Nacional de Salud Pública, Universidad de Antioquia, Medellín, Antioquia, Colombia.
  • Instituto de Investigaciones Médicas, Facultad de Medicina, Universidad de Antioquia, Medellín, Antioquia, Colombia.
  • Ministerio de Salud y Protección Social, Bogotá, Distrito Capital, Colombia.
  • Instituto Nacional de Salud, Bogotá, Distrito Capital, Colombia.
  • Pan American Health Organization (PAHO), Bogota, Distrito Capital, Colombia.

ORCID-Profile: Lina Zuluaga-Idárraga, Alexandra Rios-Orrego, Juan Esteban Martinez-López, Daniel Camilo Aguirre-Acevedo, Alberto Tobón-Castaño, Tatiana Lopera-Mesa, Iván Cardenas, Mario J Olivera, Milton Cardozo-Cruz, Guillermo Gonzalvez, Erika Venegas, Heidi Mihm, Sonia Herrera, Lawrence Barat

Förderung

  • U.S. Department of State

Zitieren

APA

Zuluaga-Idárraga, L., Rios-Orrego, A., Martinez-López, J. E., Aguirre-Acevedo, D. C., Tobón-Castaño, A., Lopera-Mesa, T., Cardenas, I., Olivera, M. J., Cardozo-Cruz, M., Gonzalvez, G., Ade, M. P., Montoya, R., Venegas, E., Mihm, H., Herrera, S., Flewelling, J., Barat, L., Wu, X., Hsiang, M. S., & Villegas, L. (2026). Prevalence of glucose-6-phosphate dehydrogenase (G6PD) deficiency in a malaria endemic region of Colombia: Implications for radical cure of Plasmodium vivax. PLOS Global Public Health, 6(11), e0007460. https://doi.org/10.1371/journal.pgph.0007460

Vancouver

Zuluaga-Idárraga L, Rios-Orrego A, Martinez-López JE, Aguirre-Acevedo DC, Tobón-Castaño A, Lopera-Mesa T, et al. Prevalence of glucose-6-phosphate dehydrogenase (G6PD) deficiency in a malaria endemic region of Colombia: Implications for radical cure of Plasmodium vivax. PLOS Global Public Health. 2026;6(11):e0007460. doi:10.1371/journal.pgph.0007460

BibTeX
@article{ZuluagaIdrraga2026,
  author = {Zuluaga-Idárraga, Lina and Rios-Orrego, Alexandra and Martinez-López, Juan Esteban and Aguirre-Acevedo, Daniel Camilo and Tobón-Castaño, Alberto and Lopera-Mesa, Tatiana and Cardenas, Iván and Olivera, Mario J and Cardozo-Cruz, Milton and Gonzalvez, Guillermo and Ade, María Paz and Montoya, Roberto and Venegas, Erika and Mihm, Heidi and Herrera, Sonia and Flewelling, Jaclyn and Barat, Lawrence and Wu, Xue and Hsiang, Michelle S and Villegas, Leopoldo},
  title = {Prevalence of glucose-6-phosphate dehydrogenase (G6PD) deficiency in a malaria endemic region of Colombia: Implications for radical cure of Plasmodium vivax},
  journal = {PLOS Global Public Health},
  year = {2026},
  volume = {6},
  number = {11},
  pages = {e0007460},
  doi = {10.1371/journal.pgph.0007460}
}
Kostenlos starten →